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Available online 12 June 2011The blockade of the lateral parabrachial nucleus (LPBN) with GABAA receptor agonist
muscimol induces robust hypertonic NaCl and water intake by rats. In the present study we
investigated the effects of previous injections of losartan (AT1 angiotensin receptor
antagonist) into the LPBN on 0.3 M NaCl and water intake induced by muscimol injected
bilaterally in the same area in fluid replete rats and in rats treated with the diuretic
furosemide combined with a low dose of the angiotensin-converting enzyme inhibitor
captopril injected subcutaneously. MaleWistar rats with stainless steel cannulas implanted
bilaterally into the LPBN were used. Bilateral injections of muscimol (0.5 nmol/0.2 μl, n=8)
into the LPBN in fluid replete rats induced 0.3 M NaCl intake (23.4±4.1 vs. saline: 0.4±
0.4 ml/3 h) and water intake (9.3±1.9 vs. saline: 0.7±0.4 ml/3 h) and pre-treatment of the
LPBNwith losartan (50 μg/0.2 μl) reduced 0.3 MNaCl intake (3.3±2.5 ml/3 h) andwater intake
(4.0±2.9 ml/3 h) induced by muscimol. In rats treated with furosemide+captopril, pre-
treatment with losartan into the LPBN attenuated the increase of 0.3 M NaCl intake
produced by muscimol (12.8±5.3, vs. saline+muscimol: 36.7±6.7 ml/3 h) without changing
water intake. Therefore, the results suggest that deactivation of LPBN inhibitory
mechanisms by muscimol injections into the LPBN is facilitated by endogenous
angiotensin II acting on AT1 receptors in the LPBN, which drives rats to ingest large
amounts of hypertonic NaCl.
© 2011 Elsevier B.V.Open access under the Elsevier OA license.Keywords:
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Lateral parabrachial nucleus1. Introduction
Important mechanisms for the control of sodium and water
intake are present in the lateral parabrachial nucleus (LPBN), a
pontine structure located dorsolaterally to the superior
cerebellar peduncle (Andrade et al., 2006; Callera et al., 2005;
De Luca et al., 2003; De Oliveira et al., 2007; Menani et al., 2002;
Menani and Johnson, 1995). The LPBN is reciprocally con-ic Science, School of Den
, Araçatuba, São Paulo, B
. Callera).
the Elsevier OA license.nected to forebrain areas, such as the paraventricular nucleus
of the hypothalamus (PVN), the central nucleus of the
amygdala (CeA) and the median preoptic nucleus (MnPO),
and to medullary regions, like the area postrema (AP) and the
medial portion of the nucleus of the solitary tract (mNTS)
(Ciriello et al., 1984; Fulwiler and Saper, 1984; Herbert et al.,
1990; Jhamandas et al., 1992, 1996; Norgren, 1981). Therefore,
the LPBN may convey signals that ascend from AP/mNTS totistry, Universidade Estadual Paulista (UNESP), Rodovia Marechal
razil. Fax: +55 18 3636 3332.
Fig. 1 – Photomicrograph of a brain slice from one rat
representative of the groups studied showing the sites of
injections into the LPBN (arrows).
29B R A I N R E S E A R C H 1 4 0 3 ( 2 0 1 1 ) 2 8 – 3 6the forebrain areas that regulate fluid and electrolyte balance
and related behaviors like water and sodium intake.
Numerous neurotransmitter systems have implicated the
LPBN in the control of sodium intake. For example, bilateral
LPBN injections of methysergide, a serotonergic receptor
antagonist, increase hypertonic NaCl intake induced by
angiotensin II (ANG II) administered intracerebroventricularly
(i.c.v.) or into the subfornical organ (SFO), by 24 h of water
deprivation, by 24 h of sodium depletion or by deoxycorticos-
terone acetate (DOCA) (De Gobbi et al., 2001; Menani et al.,
1996, 1998a, 2000; Menani and Johnson, 1995). Blockade of
cholecystokinin (CCK) or serotonin receptors or activation of
α2-adrenergic receptors in the LPBN enhances NaCl intake by
rats injected subcutaneously with the diuretic furosemide
(FURO) combined with the angiotensin converting enzyme
inhibitor captopril (CAP) (Andrade et al., 2004; De Gobbi et al.,
2001; Menani et al., 1996, 1998b). The blockade of LPBN
neurons with bilateral injections of the GABAA agonist
muscimol induces robust ingestion of hypertonic NaCl and
slight ingestion of water in fluid replete rats and increases
FURO+CAP- and 24 h sodium depletion-induced sodium
intake, suggesting that a GABAergic mechanism present in
LPBN is involved in the control of sodium intake (Callera et al.,
2005; De Oliveira et al., 2007).
The cardiovascular, neuroendocrine and ingestive effects
of ANG II acting centrally are mediated mainly by angiotensin
type 1 (AT1) receptors located in different areas of the central
nervous system, such as the LPBN, anterior hypothalamic area
(AHA), amygdala, SFO, rostral and caudal ventrolateral me-
dulla and NTS (Fitzsimons, 1998; Fregly and Rowland, 1991;
Mckinley et al., 1996; Rowland et al., 1992; Thunhorst and Fitts,
1994). The nonpeptide antagonist losartan selectively binds on
AT1 receptors (Chiu et al., 1989).
Studies using whole cell voltage-clamp techniques have
suggested that ANG II acting on AT1 receptors may modulate
GABAergic synaptic transmission and produce opposite ef-
fects, depending on whether pre- or post-synaptic AT1 re-
ceptors are activated (Henry et al., 2009; Li et al., 2003; Li and
Pan, 2005; Xing et al., 2009). It has been suggested that ANG II
acting on pre-synaptic AT1 receptors reduces GABA release
and decreases the amplitude of evoked GABAergic inhibitory
post-synaptic currents (IPSCs) (Li et al., 2003; Li and Pan, 2005;
Xing et al., 2009). In contrast, it was shown that endogenous
ANG II acting on post-synaptic AT1 receptors increases IPSCs
in sodium-sensitive neurons in the median preoptic nucleus
(MnPO) (Henry et al., 2009). According to these studies,
treatment with ANG II increased the firing of PVN neurons
that project to the rostroventrolateral medulla (RVLM) and
decreased the amplitude of evoked GABAergic IPSCs and the
frequency of miniature IPSCs, effects blocked by the AT1
receptor antagonist losartan (Li et al., 2003; Li and Pan, 2005).
Treatment with ANG II also decreased the amplitude of
evoked IPSCs and the frequency of miniature IPSCs in neurons
of the dorsolateral periaqueductal gray, an effect blocked by
losartan, but not by the AT2 antagonist PD123319 (Xing et al.,
2009). Treatment with ANG II had no effect on excitatory post
synaptic currents in the PVN neurons or in the dorsolateral
periaqueductal gray (Li et al., 2003; Li and Pan, 2005; Xing et al.,
2009). In contrast, another study showed that the amplitude of
the IPSCs in the MnPO was reduced by the treatment withlosartan, suggesting a post synaptic action of endogenous
ANG II that facilitated the effect of the GABAergic input to the
MnPO (Henry et al., 2009).
Considering the effects of the activation of GABAA re-
ceptors in the LPBN on hypertonic NaCl and water intake
(Callera et al., 2005; De Oliveira et al., 2007) and the results of
previous studies showing that AT1 receptor activation may
modulate the action of the GABAergic mechanisms (Henry et
al., 2009; Li et al., 2003; Li and Pan, 2005; Xing et al., 2009), in the
present study we investigated the effects of injections of the
specific AT1 receptor antagonist, losartan, into the LPBN on
water and hypertonic NaCl intake induced by the activation of
GABAA receptors bymuscimol injections into the LPBN in fluid
replete or FURO+CAP-treated rats.2. Results
2.1. Histological analysis
Fig. 1 is a photomicrograph of a transverse section of the
brainstem of one rat, representative of the groups tested,
showing the typical bilateral injection sites in the LPBN. The
injections were centered in the central lateral and dorsal
lateral portions of the LPBN (see Fulwiler and Saper, 1984 for
definitions of LPBN subnuclei). In some rats, LPBN injections
reached the ventral lateral and external lateral portions, as
well as the Kölliker–Fuse nucleus. The sites of injections were
similar to those in previous studies that showed the effects of
LPBN injections of methysergide, proglumide, moxonidine or
muscimol on water and 0.3 M NaCl intake (Andrade et al.,
2006; Callera et al., 2005; De Gobbi et al., 2001; De Luca et al.,
2003; De Oliveira et al., 2007). In some rats, injections spread to
the brachium (superior cerebellar peduncle), or slightly ventral
to this structure, reaching the dorsal portions of the medial
parabrachial nucleus (MPBN) uni- or bilaterally. There was no
difference in the effects if the injections were restricted to the
LPBN or if they spread to the ventral structures described
above.
30 B R A I N R E S E A R C H 1 4 0 3 ( 2 0 1 1 ) 2 8 – 3 62.2. Effects of combined injections of losartan and
muscimol into the LPBN on water and 0.3 M NaCl intake in
fluid replete rats
ANOVA showed significant differences between treatments
for 0.3 M NaCl [F(3, 21)=20.7; P<0.001] and water intake [F(3,
21)=9.05; P<0.001] in fluid replete rats that received injections
of saline or losartan combined with injections of saline or
muscimol into the LPBN (Fig. 2).
In two-bottle tests, bilateral injections of muscimol
(0.5 nmol/0.2 μl at each site, n=8) into the LPBN in fluid replete
rats induced 0.3 M NaCl intake (23.4±4.1 ml/3 h, vs. saline+
saline: 0.4±0.4 ml/3 h, Figs. 2A and B) and water intake (9.3±
1.9 ml/3 h, vs. saline+saline: 0.7±0.4 ml/3 h, Figs. 2C and D).
Previous injections of the AT1 receptor antagonist losartan
(50 μg/0.2 μl each site) into the LPBN reduced the effects of
muscimol (0.5 nmol/0.2 μl) injected in the same area on 0.3 M
NaCl intake (3.3±2.5 ml/3 h, Figs. 2A and B) and water intake
(4.0±2.9 ml/3 h, Figs. 2C and D).
The ingestion of 0.3 M NaCl and water after bilateral
injections of muscimol into the LPBN in replete rats was
significantly different from those after saline injected into the
LPBN (control) from 120 min to the end of the test (180 min)
and the pre-treatment with losartan injected into the LPBN
reduced the ingestion of 0.3 M NaCl and water in the same
period (Figs. 2A and C).Time (min)
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Fig. 2 – (A) Cumulative 0.3 M NaCl intake; (B) individual 0.3 M NaC
water intakes (180 min) by fluid replete rats treated with losartan
(0.5 nmol/0.2 μl) or saline bilaterally into the LPBN. (A and C) Val
saline+saline. +=different from saline+muscimol.Losartan injected alone into the LPBN did not affect water
or 0.3 M NaCl intake.
2.3. Effects of combined injections of losartan and
muscimol into the LPBN on FURO+CAP-induced 0.3 M NaCl
and water intake
ANOVA showed significant interactions between treatments
and times for 0.3 MNaCl intake [F(18, 126)=9.5; P<0.001] and for
water intake [F(18, 126)=4.1; P<0.001] induced by FURO+CAP in
rats that received injections of saline or losartan combinedwith
injections of saline or muscimol into the LPBN (Fig. 3).
Bilateral injections of muscimol (0.5 nmol/0.2 μl at each
site, n=8) into the LPBN increased FURO+CAP-induced 0.3 M
NaCl intake from 120 min to the end of the test (36.7±
6.7 ml/3 h, vs. saline+saline: 7.2±3.3 ml/3 h) (Figs. 3A and B).
Losartan (50 μg/0.2 μl at each site) injected into the LPBN
reduced the effects of muscimol on 0.3 M NaCl intake from
120 min to the end of the test (12.8±5.3 ml/3 h) (Figs. 3A and B).
Losartan injected alone into the LPBN produced no change in
FURO+CAP-induced 0.3 M NaCl intake.
A tendency toward the reduction of FURO+CAP-induced
water intake at 30 and 60 min of the test occurred after
injections of muscimol into the LPBN, an effect partially
reversed by pre-treatment with losartan (Fig. 3C). Losartan
injected alone into the LPBN produced no significant change in0.
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Fig. 3 – (A) Cumulative 0.3 M NaCl intake; (B) individual 0.3 M NaCl intakes (180 min); (C) cumulative water intake; (D) individual
water intakes (180 min) by FURO+CAP-treated rats that received losartan (50 μg/0.2 μl) or saline combined with muscimol
(0.5 nmol/0.2 μl) or saline bilaterally into the LPBN. (A and C) Values are means±S.E.M. n=number of rats. *=different from
saline+saline. +=different from saline+muscimol.
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with saline (Figs. 3C and D). However, opposite effects on
water intake after losartan and muscimol were injected alone
into the LPBN resulted in a significant difference between
these treatments at 60 min of the test (Fig. 3C).Table 1 – Ingestion of water and 0.3 M NaCl by fluid replete rats
combined with saline or muscimol in sites outside the LPBN (m
Fluid replete rats 0.3 M Na
(ml
Saline+saline 1.7
Saline+muscimol 3.2
Losartan+muscimol 2.7
Losartan+saline 1.6
FURO+CAP-treated rats
Saline+saline 4.3
Saline+muscimol 7.8
Losartan+muscimol 9.4
Losartan+saline 3.6
Values are means±S.E.M. n=6 rats/group. Losartan (50 μg/0.2 μl); muscim2.4. Specificity of injections into the LPBN on water and
0.3 M NaCl intake
Results from rats that received injections outside the LPBN
(misplaced injections) were analyzed to show that the effectsor FURO+CAP-treated rats that received saline or losartan
isplaced injections).
Cl intake Water intake
/3 h) (ml/3 h)
±0.3 3.4±0.3
±0.7 2.5±0.5
±0.6 2.8±0.5
±0.2 1.5±0.3
±1.3 7.1±2.5
±2.8 6.0±2.3
±5.1 5.4±2.5
±1.8 2.6±1.0
ol (0.5 nmol/0.2 μl).
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activation of GABAA receptors in the LPBN. Bilateral injections
of muscimol or losartan alone or of muscimol combined with
losartan in sites outside the LPBN did not affect water and
0.3 M NaCl intake in fluid replete rats or FURO+CAP-treated
rats (Table 1). ANOVA showed no significant differences
between treatments for 0.3 M NaCl intake [F(3, 12)=3.0;
P>0.05] or water intake [F(3, 12)=4.0; P>0.05] in fluid replete
rats or between treatments for 0.3 M NaCl intake [F(3, 15)=0.9;
P>0.05] or water intake [F(3, 15)=3.3; P>0.05] in FURO+CAP-
treated rats that received injections in sites outside the LPBN.
Misplaced injections were ventral (MPBN), dorsal or rostral
to the LPBN. Some rats had unilateral injections partially into
the LPBN.3. Discussion
Similar to previous results (Callera et al., 2005; De Oliveira et
al., 2007), the present study shows that bilateral injections of
muscimol (GABAA receptor agonist) into the LPBN induce
hypertonic NaCl and water ingestion in fluid replete rats
(untreated rats) and increase 0.3 M NaCl intake in FURO+CAP-
treated rats. The involvement of GABAA receptors of the LPBN
in the control of water and NaCl intake is supported by a
previous study showing that the GABAA receptor antagonist
bicuculline injected into the LPBN completely blocked water
and hypertonic NaCl intake induced by muscimol, which
suggests that muscimol activates LPBN GABAA receptors to
increase sodium intake (Callera et al., 2005). The present
results extend the conclusions of the previous study by
showing that pretreatment of the LPBN with bilateral in-
jections of the nonpeptide AT1 receptor antagonist losartan
reduce water and 0.3 M NaCl intake caused by muscimol
injected into the same site in fluid replete rats, as well as the
increase in 0.3 M NaCl produced by muscimol injected
bilaterally into the LPBN in FURO+CAP-treated rats. Injections
of losartan alone into the LPBN did not change water or 0.3 M
NaCl intake by untreated rats or FURO+CAP-treated rats.
Results from rats with misplaced injections confirm that
muscimol effects on water and 0.3 M NaCl intake are specific
to the LPBN. The results also suggest that angiotensinergic
mechanisms in the LPBN are essential for the dipsogenic and
natriorexigenic responses induced by the blockade of LPBN
neurons with muscimol in fluid replete rats or the increase in
the natriorexigenic responses produced by muscimol injected
into the LPBN in FURO+CAP-treated rats.
Pretreatment with losartan into the LPBN reduced musci-
mol effects on water and/or NaCl intake by fluid replete or
FURO+CAP-treated rats. Therefore, if endogenous GABA
release in the LPBN was important for FURO+CAP-induced
water and sodium intake, similar effects would be expected
when losartan alone was injected in FURO+CAP-treated rats.
However, injections of losartan alone did not modify FURO
+CAP-induced water or NaCl intake, suggesting that GABA
release or its interaction with activated AT1 receptors in the
LPBN is not essential for sodium or water intake induced by
FURO+CAP. Perhaps any reduction of GABA effects by losartan
was compensated for by changes in the release of other
neurotransmitters in the LPBN like serotonin, CCK, cortico-tropin-releasing hormone (CRF), glutamate, opioids or nor-
adrenaline that also modulate water and sodium intake (De
Castro e Silva et al., 2006; De Oliveira et al., 2008; De Gobbi et
al., 2009; Gasparini et al., 2009; Menani et al., 1996; Menani and
Johnson, 1998).
AT1 receptors and ANG II terminals are present in the LPBN
(Lenkei et al., 1997; Mckinley et al., 2002); however, we found
no clear evidence in the literature of ANG II effects in the LPBN.
The present results suggest that ANG II acting on AT1
receptors in LPBN is necessary for the full effects of muscimol
injected into the LPBN on water and sodium intake. The
treatment with FURO+CAP increases ANG II centrally (Thun-
horst and Johnson, 1994). However, it is possible that
activation of AT1 receptors by baseline levels of ANG II in
fluid replete rats is sufficient to facilitate the increase in water
and sodium intake produced by muscimol in the LPBN. On the
other hand, although there is no evidence that injections of
muscimol into the LPBN increase ANG II levels, the present
results do not allow us to exclude the possibility of an increase
in central or peripheral levels of ANG II due to muscimol
injections into the LPBN. The ingestion of sodium after
muscimol injections into the LPBN takes at least 1 h to start,
which is time enough for changes in the levels of ANG II within
the LPBN that may intensify the effects of muscimol on LPBN
neurons, a step necessary for the release of sodium intake.
The cardiovascular, neuroendocrine and ingestive effects
of ANG II acting centrally are mediated mainly by AT1
receptors (Fitzsimons, 1998; Kirby et al., 1992; Mckinley et al.,
1996; Rowland et al., 1992; Saavedra, 1994; Thunhorst and
Fitts, 1994). For example, ingestion of water and NaCl is
suggested to depend on the action of circulating ANG II on
circumventricular organs like the SFO and OVLT (Krause et al.,
2008; Morris et al., 2002; Thunhorst and Fitts, 1994). At the
same time, AT1 receptors have a role in mediating an
enhanced sodium intake produced by blockade of LPBN
inhibitory mechanisms with injections of the serotonergic
antagonist methysergide (Colombari et al., 1996; Menani et al.,
1998b). More specifically, injections of methysergide into the
LPBN combinedwith treatments that increase ANG II centrally
or peripherally, such as FURO+CAP sc, isoproterenol or acute
(1 h previous) treatment with FURO, also produce robust
ingestion of 0.3 M NaCl (Menani et al., 1998a, 2000). Whereas
treatmentwith FURO+CAP alone induces significant ingestion
of NaCl, sc treatments with isoproterenol or acute furosemide
do not produce significant ingestion of NaCl, despite increases
in ANG II signaling, unless LPBN inhibitory mechanisms are
deactivated. Therefore, sodium intake does not always
increase even with increased levels of ANG II. However, if
the LPBN inhibitorymechanisms are deactivated, then ANG II-
induced sodium and water intake is strongly facilitated.
In addition to methysergide, the blockade of other neuro-
transmitters in the LPBN like CCK, CRF or glutamate, or
activation of α2 adrenoceptors with noradrenaline or mox-
onidine, deactivate LPBN inhibitory mechanisms and increase
sodium and water intake induced by treatment with FURO+
CAP (Andrade et al., 2004; De Castro e Silva et al., 2006; De
Gobbi et al., 2001; Gasparini et al., 2009; Menani et al., 1996;
Menani and Johnson, 1998). The blockade of these neuro-
transmitters or activation of α2 adrenoceptors in the LPBN
produces no sodium or water intake in fluid replete rats,
33B R A I N R E S E A R C H 1 4 0 3 ( 2 0 1 1 ) 2 8 – 3 6which might suggest that sodium intake easily arises only
when facilitatory mechanisms are activated and inhibitory
mechanisms are simultaneously deactivated. However, in
contrast to the blockade of the other neurotransmitters or α2
adrenoceptor activation, either opioid (β endorphin) or
GABAergic (muscimol) activation of the LPBN induces robust
ingestion of water and 0.3 M NaCl in fluid replete rats,
suggesting that the deactivation of LPBN inhibitory mecha-
nisms alone is sufficient to drive rats to ingest hypertonic NaCl
(Callera et al., 2005; De Oliveira et al., 2007, 2008). Substantial
ingestion of sodium starts ~2–3 h after muscimol injections
into the LPBN in untreated rats (Callera et al., 2005, present
results). The present results also show an increased sodium
intake 2–3 h after injections of muscimol into the LPBN in
FURO+CAP-treated rats.
Injections of muscimol into the LPBN produces a small
increase on arterial pressure and non-significant effects on
renal excretion in fluid replete rats (Callera et al., 2005; De
Oliveira et al., 2007), which suggests that sodium intake
produced by muscimol into the LPBN is not secondary to
decreases in blood pressure or an increase in urinary sodium
excretion. Rather, ingestion of hypertonic NaCl solutions
increases the activity of LPBN neurons, suggesting that the
LPBN can be activated by taste and/or visceral stimuli
(Franchini and Vivas, 1999; Yamamoto et al., 1993). Signals
from volume, taste and other visceral receptors that may
participate in the control of water and sodium intake reach the
AP/mNTS before ascending to the LPBN which, in turn, sends
projections to forebrain areas involved in the control of fluid
and electrolyte balance, such as the SFO, MnPO, PVN and
amygdala (Ciriello et al., 1984; Jhamandas et al., 1992; Krukoff et
al., 1993; Norgren, 1981; Shapiro and Miselis, 1985). A recent
study showed that bilateral lesions of the CeA abolished water
and 0.3 M NaCl intake produced by the blockade of LPBN
neurons with muscimol in fluid replete rats, suggesting that
facilitatorymechanisms present in the CeA are essential for the
dipsogenic and natriorexigenic responses induced bymuscimol
injected into the LPBN (Andrade-Franzé et al., 2010). Consistent
with this idea, the CeA contains AT1 receptors and has been
proposed as a possible site of interaction between ANG II and
mineralocorticoids to stimulate sodium appetite (Galaverna et
al., 1992; McKinley et al., 2002).
AT1 receptors are present in different areas of the brain,
including the LPBN (Fitzsimons, 1998; Mckinley et al., 1996).
Modulation of GABAergic neurotransmission by ANG II de-
pends upon whether the AT1 receptors are located pre- or post-
synaptically. Activation of pre-synaptic AT1 receptors reduce
the effects of GABAergic activation, whereas activation of post-
synaptic AT1 receptors increase the effects (Henry et al., 2009; Li
et al., 2003; Li and Pan, 2005; Xing et al., 2009). The present
results show that blockade of AT1 receptors by the injection of
losartan into the LPBN reduces hypertonic NaCl and water
intake stimulated by the activation of LPBN GABAA receptors
with muscimol injected in the same area in fluid replete or in
FURO+CAP-treated rats. Thus, it appears that ANG II acts on
post-synaptic AT1 receptors in the LPBN to enhance the
activation of GABA receptors with muscimol via a mechanism
similar to that described in theMnPO (Henry et al., 2009). Taken
together, these results suggest that interactions of angiotensi-
nergic and GABAergic mechanisms in the LPBN are importantto stimulate sodium intake. In other words, the action of ANG II
on AT1 receptors in the LPBN is important for the inhibition of
LPBN neurons, thereby facilitating sodium intake produced by
activation of GABAergic mechanisms in the LPBN.4. Experimental procedures
4.1. Animals
Male Wistar rats weighing 290–310 g were used. The animals
were housed in individual stainless steel cages with free
access to standard sodium diet (Guabi Rat Chow, Paulinia, SP,
Brazil), water and 0.3 M NaCl solution. The positions of the
bottles containing water and 0.3 M NaCl were rotated daily to
avoid place preference. Room temperature was maintained at
23±2 °C and humidity was maintained at 55±10% on a 12:12
light–dark cycle with light onset at 07:30 AM.
The procedures were approved by the Institutional Ethical
Committee for Animal Care from the School of Dentistry,
UNESP, Araçatuba, Brazil (Proc. CEEA no. 986/2007) and
followed the recommendations from the Brazilian College of
Animal Experimentation (COBEA) and the American National
Institute of Health Guide for the Care and Use of Laboratory
Animals (NIH publications No. 80–23, 1996, USA).
All efforts were made to minimize animal discomfort and
the number of animals used.
4.2. Cerebral cannulas
Rats were anesthetized with subcutaneous (sc) ketamine
(80 mg/kg of body weight, Cristália, Brazil) combined with
xylazine (7 mg/kg of bodyweight, Agener, Brazil) and placed in
a stereotaxic instrument (Kopf, USA). The skull was leveled
between bregma and lambda. Stainless steel guide-cannulas
(12×0.6 mm o.d.) were implanted bilaterally into the LPBN
using the following coordinates: 9.2 mm caudal to bregma,
2.2 mm lateral to the midline, and 3.8 mm below the dura
mater (Paxinos and Watson, 1997). The tips of the cannulas
were positioned 2 mm above each LPBN. The cannulas were
fixed to the cranium using dental acrylic resin and jeweler
screws and were filled with 30-gauge metal obturators
between tests. After the surgery, the rats received intramus-
cular injections of the analgesic cetoprophen 1% (0.03 ml) and
a prophylactic dose of the antibiotic penicillin (30,000 IU). Rats
were allowed to recover for 5 days before starting ingestion
tests and during this period they had free access to standard
sodium diet, water and 0.3 M NaCl solution.
4.3. Injections into the LPBN
Bilateral injections into the LPBN were made using 5-μl
Hamilton syringes connected by polyethylene tubing (PE-10)
to 30-gauge injection cannulas. At the time of testing,
obturators were removed and the injection cannula (2 mm
longer than the guide cannula) was carefully inserted into the
guide cannula. For bilateral injections, the first injection was
performed on one side, the needle was removed and reposi-
tioned on the contra lateral side, and then the second injection
made. Therefore injections were made ~1 min apart. The
34 B R A I N R E S E A R C H 1 4 0 3 ( 2 0 1 1 ) 2 8 – 3 6injection volume into the LPBN was 0.2 μl on each site. The
obturators were replaced after the injections, and the rats
were placed back into their cages.
4.4. Drugs
Furosemide (FURO) (Sigma-Aldrich, Saint Louis, MO, USA) was
dissolved in alkaline saline (pH adjusted to 9.0) and adminis-
tered sc at the dose of 10 mg/kg of body weight (bw). Captopril
(CAP) (Sigma-Aldrich, Saint Louis, MO, USA), was dissolved in
0.15 M NaCl and administered sc at the dose of 5 mg/kg of bw.
Muscimol HBr and losartan potassium (Sigma-Aldrich,
Saint Louis, MO, USA) were dissolved in 0.15 M NaCl. The
dose of muscimol used in the present study was the same as
that used in previous studies that investigated the effects of
muscimol injected into the LPBN on water and 0.3 M NaCl
intakes (Callera et al., 2005; De Oliveira et al., 2007). This dose
of muscimol produces a long-lasting action (at least for 1 h)
when injected into the LPBN (Callera et al., 2005). The dose of
losartan was based on previous studies that have tested the
effects of central injections of losartan on water and sodium
intake and on the pressor response to ANG II (Grippo et al.,
2002; Menani et al., 2004). The dose of losartan used is effective
for at least 2 h (Menani et al., 2004).
4.5. Water and 0.3 M NaCl intake by fluid replete rats
The rats were tested in their home cages. Water and 0.3 M
NaCl were provided from burettes with 0.1-ml divisions that
were fitted withmetal drinking spouts. Food was not available
during the tests. Measurements were taken at 30-min in-
tervals for 180 min, starting 10 min after bilateral injections of
muscimol (0.5 nmol/0.2 μl) or saline (0.2 μl) into the LPBN.
Fluid replete rats that received no pre-treatment (n=14),
were tested for the effects of the combination of losartan and
muscimol injections into the LPBN on water and 0.3 M NaCl
intake. Losartan (50 μg/0.2 μl) was injected into the LPBN
10 min before muscimol (0.5 nmol/0.2 μl). These rats were
submitted to four tests and received the following combina-
tions of treatments into the LPBN: saline+saline, saline+
muscimol, losartan+muscimol and losartan+saline. In each
test, the group of rats was divided in two and half of the group
received one of the combination of treatments listed above,
while the remaining animals received another combination of
treatments into the LPBN. The sequence of the treatments was
randomized for each rat so that, at the end of testing, rats had
received all four treatments. A recovery period of at least
2 days was allowed between tests.
4.6. Water and 0.3 M NaCl intake by FURO+CAP-treated rats
Another group of rats (n=14) was used to test water and 0.3 M
NaCl intake induced by treatment with FURO+CAP sc. On the
day of the experiment, food, water and 0.3 M NaCl were
removed and the cages were rinsed with water. Rats received
sc injections of the diuretic FURO (10 mg/kg bw) plus CAP
(5 mg/kg bw) as described previously (Callera et al., 2005; De
Gobbi et al., 2001; Menani et al., 1996; Thunhorst and Johnson,
1994). One hour after FURO+CAP treatment, burettes with
water and 0.3 M NaCl solution were returned and measure-ments were taken at 30-min intervals for 180 min (sodium
appetite test). Ten minutes before access to water and 0.3 M
NaCl, rats received bilateral injections of muscimol
(0.5 nmol/0.2 μl) or saline into the LPBN. Bilateral injections
of losartan (50 μg/0.2 μl) or saline into the LPBN were
performed 10 min before the injections of muscimol or saline
into the LPBN. In each experimental session, the group of rats
was divided in two and each half of the group received one of
the four treatments in the LPBN: saline+saline, saline+
muscimol, losartan+muscimol and losartan+saline. The
sequence of the treatments was in a randomized order so
that at the end of testing, rats had received all four treatments.
A recovery period of at least 3 days was allowed between
experimental sessions. The order of treatments was random-
ized because repeated FURO+CAP injections enhances stim-
ulated and spontaneous NaCl intake (Pereira et al., 2010).
4.7. Histology
At the end of the experiments, the animals received bilateral
injections of 2% Evans blue dye solution (0.2 μl/injection site)
into the LPBN. They were then deeply anesthetized with
sodium thiopental (CRISTALIA, Itapira, SP, Brazil, 80 mg/kg of
body weight) and perfused transcardially with saline followed
by 10% formalin. The brains were removed, fixed in 10%
formalin, frozen, cut in 60 μm sections, stained with Giemsa,
and analyzed by light microscopy to confirm the injection
sites in the LPBN.
4.8. Data analysis
The results are reported as means±S.E.M. Water and 0.3 M
NaCl intake was analyzed by two-way analysis of variance
(ANOVA) with repeated measures for both factors (treatments
and times), followed by Newman–Keuls post hoc test.
Differences were considered significant at P<0.05. The soft-
ware used for the analysis was SigmaStat for Windows,
version 2.03 from SPSS Inc.Acknowledgments
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